Marea Therapeutics to Present Late-Breaking Data at 93rd EAS Congress (Health & Beauty - Health Services)
Hot-Web-Ads > Health & Beauty > Health Services
Item ID 16187355 in Category: Health & Beauty - Health Services
Marea Therapeutics to Present Late-Breaking Data at 93rd EAS Congress | |
Marea Therapeutics, Inc., a clinical-stage biotechnology company, has announced its upcoming participation in the 93rd European Atherosclerosis Society (EAS) Congress, set to take place from May 4-7, 2025, in Glasgow, UK. The company will present two key studies, showcasing its cutting-edge research and advancements in cardioendocrine diseases, a field where they are pioneering innovative treatment approaches. Founded with a focus on transforming the treatment of cardioendocrine diseases, Marea Therapeutics harnesses human genetics to design next-generation medicines. The company’s research aims to address unmet medical needs, particularly in metabolic dysfunction and cardiovascular diseases. Marea’s pipeline includes promising treatments targeting both cardiovascular and endocrine diseases, with its lead program, MAR001, currently in Phase 2 clinical development. For more details please visit our website - https://www.medhealthinsight.com/marea-therapeutics-to-present-late-breaking-data-at-93rd-eas-congress/  | |
| Related Link: Click here to visit item owner's website (0 hit) | |
| Target State: New York Target City : New York City Last Update : Sep 04, 2025 5:35 AM Number of Views: 32 | Item Owner : medhealthinsight Contact Email: (None) Contact Phone: (None) |
| Friendly reminder: Click here to read some tips. | |
Hot-Web-Ads > Health & Beauty > Health Services
© 2025 Hot-Web-Ads.com
USNetAds.com | GetJob.us | CANetAds.com | UKAdsList.com | AUNetAds.com | INNetAds.com | CNNetAds.com | USAOnlineClassifieds.com
2025-09-14 (0.326 sec)